tetanus - toxoid injection (Tetanus Toxoid Adsorbed) (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:

Rare but serious side effects include:

Rare cases of anaphylactic shock have been reported after receiving some preparations containing the tetanus toxoid.



PREPARATIONS: Vial: 0.5 ml unit dose & 5 ml vial

STORAGE: Tetanus toxoid vaccines should be refrigerated between 2.2 C and 7.7 C (36 F and 46 F). Do not freeze.

DOSING: The recommended dose is 0.5 ml injected intramuscularly. Repeat at 4 to 8 weeks after the first dose and at 6 to 12 months after the second dose.


Some medications may decrease the therapeutic benefits of the tetanus toxoid vaccine. Example of such medications include:

PREGNANCY: Tetanus toxoid is classified as FDA pregnancy risk category C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks. Adequate and well-controlled studies of the tetanus toxoid vaccine in pregnant women are lacking.

NURSING MOTHERS: It is not known if tetanus toxoid is excreted in breast milk.

REFERENCE: FDA Prescribing Information.

Medically Reviewed by a Doctor on 12/22/2014

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.

Back to Medications Index